Fusafungine: Difference between revisions
CSV import |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 29: | Line 29: | ||
{{Respiratory system}} | {{Respiratory system}} | ||
{{Pharmacology-stub}} | {{Pharmacology-stub}} | ||
<gallery> | |||
File:Fusafungine_structure.svg|Fusafungine structure | |||
</gallery> | |||
Latest revision as of 23:32, 16 March 2025
Fusafungine is a fungal antibiotic that is used in the treatment of various respiratory tract infections. It is a complex polypeptide antibiotic that is produced by the fungus Fusarium lateritium. Fusafungine has both antibacterial and anti-inflammatory properties, making it effective against a wide range of bacteria and inflammation.
History[edit]
Fusafungine was first isolated in the 1950s from the fungus Fusarium lateritium. It was initially used in the treatment of skin infections, but its use has since expanded to include respiratory tract infections.
Mechanism of Action[edit]
Fusafungine works by inhibiting the synthesis of protein in bacteria, thereby preventing their growth and reproduction. It also has anti-inflammatory properties, which help to reduce the symptoms of inflammation in the respiratory tract.
Medical Uses[edit]
Fusafungine is used in the treatment of various respiratory tract infections, including rhinitis, pharyngitis, tonsillitis, and laryngitis. It is also used in the treatment of sinusitis and bronchitis. Fusafungine is typically administered as a nasal spray or inhaler, allowing for direct application to the affected areas of the respiratory tract.
Side Effects[edit]
Like all medications, fusafungine can cause side effects. These may include nausea, vomiting, diarrhea, and allergic reactions. In rare cases, fusafungine can cause severe allergic reactions, including anaphylaxis.
See Also[edit]
| Anatomy of the lower respiratory tract | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
-
Fusafungine structure
